Terms: = Pancreatic cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Treatment
12 results:
1. FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision-making in real-world.
Marschner N; Hegewisch-Becker S; Reiser M; von der Heyde E; Bertram M; Hollerbach SH; Kreher S; Wolf T; Binninger A; Chiabudini M; Kaiser-Osterhues A; Jänicke M;
Int J Cancer; 2023 Feb; 152(3):458-469. PubMed ID: 36053905
[TBL] [Abstract] [Full Text] [Related]
2. Plant Alkaloid Tetrandrine Is a Nuclear Receptor 4A1 Antagonist and Inhibits Panc-1 Cell Growth In Vitro and In Vivo.
Lee HS; Kim DH; Lee IS; Park JH; Martin G; Safe S; Kim KJ; Kim JH; Jang BI; Lee SO
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563670
[TBL] [Abstract] [Full Text] [Related]
3. Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials.
Zhu AX; Nipp RD; Finn RS; Galle PR; Llovet JM; Blanc JF; Okusaka T; Chau I; Cella D; Girvan A; Gable J; Bowman L; Wang C; Hsu Y; Abada PB; Kudo M
ESMO Open; 2020 Aug; 5(4):. PubMed ID: 32817068
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of treatment patterns, resource utilization, and cost of care in patients with metastatic pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine or FOLFIRINOX.
Kim GP; Parisi MF; Patel MB; Pelletier CL; Belk KW
Expert Rev Clin Pharmacol; 2017 May; 10(5):559-565. PubMed ID: 28286977
[TBL] [Abstract] [Full Text] [Related]
5. Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish ttd Collaborative Group.
Irigoyen A; Gallego J; Guillén Ponce C; Vera R; Iranzo V; Ales I; Arévalo S; Pisa A; Martín M; Salud A; Falcó E; Sáenz A; Manzano Mozo JL; Pulido G; Martínez Galán J; Pazo-Cid R; Rivera F; García García T; Serra O; Fernández Parra EM; Hurtado A; Gómez Reina MJ; López Gomez LJ; Martínez Ortega E; Benavides M; Aranda E;
Eur J Cancer; 2017 Apr; 75():73-82. PubMed ID: 28222309
[TBL] [Abstract] [Full Text] [Related]
6. ttd consensus document on the diagnosis and management of exocrine pancreatic cancer.
Benavides M; Abad A; Ales I; Carrato A; Díaz Rubio E; Gallego J; García-Foncillas J; Grávalos C; Laquente B; Pericay C; Rivera F; Tabernero J; Aranda E
Clin Transl Oncol; 2014 Oct; 16(10):865-78. PubMed ID: 24728654
[TBL] [Abstract] [Full Text] [Related]
7. Predictive role of repair enzymes in the efficacy of Cisplatin combinations in pancreatic and lung cancer.
Peters GJ; Avan A; Ruiz MG; Orsini V; Avan A; Giovannetti E; Smit EF
Anticancer Res; 2014 Jan; 34(1):435-42. PubMed ID: 24403499
[TBL] [Abstract] [Full Text] [Related]
8. Identification of distinct phenotypes of locally advanced pancreatic adenocarcinoma.
Teo M; Crotty GF; O'Súilleabháin C; Ridgway PF; Conlon KC; Power DG; McDermott RS
J Gastrointest Cancer; 2013 Mar; 44(1):73-8. PubMed ID: 22829058
[TBL] [Abstract] [Full Text] [Related]
9. Septated cystic tumors of the pancreas: is it possible to treat them by endoscopic ultrasonography-guided intervention?
Oh HC; Seo DW; Kim SC; Yu E; Kim K; Moon SH; Park DY; Lee SS; Lee SK; Kim MH
Scand J Gastroenterol; 2009; 44(2):242-7. PubMed ID: 18949629
[TBL] [Abstract] [Full Text] [Related]
10. Patient-reported outcomes as a component of the primary endpoint in a double-blind, placebo-controlled trial in advanced pancreatic cancer.
Eckhardt SG; De Porre P; Smith D; Maurel J; Steward WP; Bouche O; van de Velde H; Michiels B; Bugat R
J Pain Symptom Manage; 2009 Feb; 37(2):135-43. PubMed ID: 18723314
[TBL] [Abstract] [Full Text] [Related]
11. A phase II trial of gemcitabine and weekly high-dose 5-fluorouracil in a 48-hour continuous-infusion schedule in patients with advanced pancreatic carcinoma. A study of the Spanish Cooperative Group for Gastrointestinal Tumour Therapy (ttd).
Santasusana JM; García López JL; García JJ; Carbonero AI; Plazas JG; Rovira PS; Martos CF; Guzmán MC; Jericó JF; Delgado FJ; Espinosa JC; Muñoz ML; Aguilar EA; Valera JS; García Ribas I; Mena AC
Clin Transl Oncol; 2005 Dec; 7(11):493-8. PubMed ID: 16373060
[TBL] [Abstract] [Full Text] [Related]
12. Apoptosis-induction and phosphorylation state in human pancreatic carcinoma xenografts following octreotide treatment.
Zalatnai A; Pogány V
Anticancer Res; 2001; 21(1A):477-80. PubMed ID: 11299782
[TBL] [Abstract] [Full Text] [Related]
